Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56.75	32.79	24.46	18.89	30.37
Short-Term Investments	20.58	24.15	33.75	106.08	26.95
Cash & Short-Term Investments	77.32	56.93	58.21	124.97	57.33
Cash Growth	35.81%	-2.19%	-53.42%	117.99%	-41.55%
Receivables	41.62	30.55	40.32	15.47	15.97
Inventory	9.8	5.52	17.38	6.62	5.64
Prepaid Expenses	6.37	6.26	-	7.41	10.05
Total Current Assets	135.1	99.27	115.9	154.47	88.98
Property, Plant & Equipment	0.34	1.03	2.79	11.89	20.57
Other Intangible Assets	27.1	13.88	14.95	-	-
Other Long-Term Assets	1.44	3.06	0.64	0.97	0.82
Total Assets	163.98	117.23	134.28	167.33	110.38
Accounts Payable	3.34	7.14	22.51	3.8	3.71
Accrued Expenses	46.33	29.28	31.91	31.75	24.01
Current Portion of Long-Term Debt	7.27	10.87	3.94	7.97	-
Current Portion of Leases	0.29	0.69	1.13	9.89	8.62
Current Unearned Revenue	1.36	1.36	1.37	2.6	3.02
Other Current Liabilities	4.72	3.93	4.36	7.55	1.49
Total Current Liabilities	63.3	53.27	65.21	63.55	40.84
Long-Term Debt	92.39	92.32	81.71	72.64	19.82
Long-Term Leases	-	0.29	0.97	0.76	10.65
Other Long-Term Liabilities	5	-	-	-	5.05
Total Liabilities	160.69	145.87	147.9	136.95	76.35
Common Stock	0.02	0.02	0.17	0.17	0.17
Additional Paid-In Capital	1,393	1,379	1,369	1,354	1,340
Retained Earnings	-1,390	-1,408	-1,382	-1,324	-1,306
Comprehensive Income & Other	0.01	0.01	-0.15	-0.1	-0
Shareholders' Equity	3.29	-28.64	-13.62	30.37	34.03
Total Liabilities & Equity	163.98	117.23	134.28	167.33	110.38
Total Debt	99.95	104.17	87.75	91.27	39.09
Net Cash (Debt)	-22.63	-47.23	-29.55	33.7	18.24
Net Cash Growth	-	-	-	84.77%	-70.47%
Net Cash Per Share	-1.28	-2.71	-1.73	1.98	1.08
Filing Date Shares Outstanding	17.86	17.54	17.37	17.17	17
Total Common Shares Outstanding	17.71	17.48	17.34	17.16	16.93
Working Capital	71.8	46	50.69	90.91	48.14
Book Value Per Share	0.19	-1.64	-0.79	1.77	2.01
Tangible Book Value	-23.81	-42.52	-28.57	30.37	34.03
Tangible Book Value Per Share	-1.34	-2.43	-1.65	1.77	2.01
Machinery	0.28	1.83	9.48	16.04	15.53
Construction In Progress	-	-	-	0.69	0.82
Leasehold Improvements	-	-	2.11	-	-

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q